Boston, MA, United States of America

Jason Windham Reeves

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Jounce Therapeutics, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason Windham Reeves. Retrieved from https://idiyas.com/inventor/jason-windham-reeves

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jason Windham Reeves: Innovator in Gene Expression Technology

Introduction

Jason Windham Reeves is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of gene expression technology, particularly in understanding ICOS expression levels. His work has implications for treatment methods that utilize anti-ICOS antibodies.

Latest Patents

Reeves holds a patent titled "Gene signatures for determining ICOS expression." This patent provides gene expression signatures that correlate with ICOS expression levels. The methods outlined in the patent include determining ICOS expression levels in patients and administering anti-ICOS antibodies as a treatment option.

Career Highlights

Reeves is currently associated with Jounce Therapeutics, Inc., where he continues to advance research in immunotherapy. His innovative approach to gene signatures has positioned him as a key figure in the development of new therapeutic strategies.

Collaborations

Reeves has collaborated with notable colleagues such as Igor Feldman and Christopher Harvey. Their combined expertise enhances the research efforts at Jounce Therapeutics, Inc.

Conclusion

Jason Windham Reeves is a pioneering inventor whose work in gene expression technology is paving the way for new treatment methodologies. His contributions are vital to the ongoing advancements in immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…